Study Group: Psychiatrists (US)
Council Members in this Study Group: 1136
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- David Rosenberg
Chief of Psychiatry and Psychology
CHILDREN'S HOSPITAL OF MICHIGAN
David Rosenberg, MD, is a tenured professor and Miriam L Hamburger Endowed Chair of Psychiatry at Wayne State University and the Children's Hospital of Michigan. He is a board certified general and adult psychiatrist and pediatric psychiatrist. Dr. Rosenberg...
Amit VijapuraOwner
AMIT VIJAPURA MDAmit Vijapura, MD, is a Private Practitioner in Psychiatry based in Florida. He has over 15 years of experience in the field and has expertise in depression, bipolar disorder, anxiety disorder, attention deficient disorder, and schizophrenia. Dr. Vijapura...
- Robert Schulte
Psychiatrist
North Scottsdale Psychiatric SpecialistsRobert Schulte, MD, is a Private Practitioner and a Psychiatrist at North Scottsdale Psychiatric Specialists in Arizona. He is board certified in Adult Psychiatry and Child and Adolescent Psychiatry with extensive experience with children and adult's...
- Rami Kaminski
Founder and Director
Institute for Integrative PsychiatryRami Kaminski, MD, is Director and Founder of the Institute for Integrative Psychiatry in New York, a not-for-profit organization aimed at evaluating current psychiatric services and how they integrate with medicine, such as the mutual effects between...
- Lawrence Ginsberg
President
RED OAK PSYCHIATRY ASSOCIATES, P. A.Lawrence Ginsberg, MD, is President and CEO of Red Oak Psychiatry Associates, PA, a multidisciplinary mental health group in Houston, Texas. Dr. Ginsberg's research interests include psychopharmacology, addiction medicine, and forensic psychiatry. His...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Gene Targeted Drug Therapy for Heart Failure
September 23, 2008
Analysis by: Joseph Bertino, Independent Consultant,Gene Targeted Drug Therapy for Heart Failure | www.bio-medicine.org
-Another step towards invididualized medicine -Proves that old drugs can be reinvented for useful purposes -Advances pharmacogenetics forward
-
Astra-Zeneca and Abbott partner on promoting Crestor..should Pfizer beware?
August 15, 2008
Analysis by: Joseph Bertino, Independent Consultant,Abbott signs deal to promote Crestor in U.S. | www.chicagotribune.com
-Crestor sold 2.8 billion dollars in sales in the recent year, will this partnership result in long term exponential growth? -What are the implications for Crestor with generic simvastatin and with Lipitor going generic in the next few years? -Is a combination product going to bolster Crestor sales?
-
The New PhRMA “Code on Interactions with Health Care Professionals”: What will it mean?
July 17, 2008
Analysis by: Joseph Bertino, Independent Consultant,PhRMA “Code on Interactions with Health Care Professionals” | www.thepinksheet.com
-The new code will limit all gifts and meals to healthcare professionals, thus reducing pharmaceutical representative contact time. -Medical education programs will follow guidelines established by professional education groups -The guidelines do not go far enough for sales representative-healthcare professional interactions
-
Neuronal nicotinic receptor agonists potential breakthrough for ADHD research
May 12, 2008
Abbott Scientists Present A New Approach for Treating Attention-Deficit Hyperactivity Disorder | biz.yahoo.com
1. Effective treatment for ADHD 2. Well tolerated with few side effects 3. Help with smoking, a big problem in ADHD patients important 4. Advantage in not being Schedule II may be helpful
-
Important New Data for Children and Adolescents
May 12, 2008
FDA Approves Strattera® for Maintenance of ADHD in Children and Adolescents | newsroom.lilly.com
1. Important new finding given safety concerns raised about this and other treatmetns 2. Nice to have data back up what has long been done clinically 3. Stimulants still first line and lack of active comparator trial
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
- Government/Military Hospital or Clinic
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Owner
- Physician - Director
- Director
- Medical Director
- President
- Professor
Related Study Groups
| Study Group Name | No. Members |
|---|---|
| Psychiatrists | 1535 |
| Physicians who Treat Schizophrenia (US) | 364 |
| Physicians who Treat ADHD (US) | 453 |
| Child and Adolescent Psychiatrists (US) | 177 |
| Physicians who Treat Depression (US) | 448 |
| Effexor XR Prescribers (US) | 144 |
| Psychiatrists who Treat Mood Disorders (US) | 117 |
| Mood Disorder Psychiatrists | 165 |